Cross Country Healthcare (NASDAQ:CCRN) Issues Q2 Earnings Guidance

Cross Country Healthcare (NASDAQ:CCRN) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $0.10-0.20 for the period, compared to the consensus EPS estimate of $0.19. The company issued revenue guidance of $330-340 million, compared to the consensus revenue estimate of $362.62 million.

Cross Country Healthcare Stock Up 1.7 %

NASDAQ:CCRN traded up $0.30 on Wednesday, hitting $17.90. The stock had a trading volume of 539,558 shares, compared to its average volume of 443,287. The stock has a market cap of $620.77 million, a price-to-earnings ratio of 8.58, a PEG ratio of 1.91 and a beta of 0.75. The company has a fifty day moving average price of $17.92 and a two-hundred day moving average price of $20.12. Cross Country Healthcare has a 1-year low of $15.65 and a 1-year high of $28.75.

Cross Country Healthcare (NASDAQ:CCRN) last posted its earnings results on Wednesday, February 21st. The business services provider reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.02. The company had revenue of $414.04 million for the quarter, compared to analyst estimates of $404.42 million. Cross Country Healthcare had a net margin of 3.60% and a return on equity of 16.93%. Cross Country Healthcare’s revenue was down 34.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.09 EPS. As a group, analysts anticipate that Cross Country Healthcare will post 0.92 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CCRN. Benchmark decreased their price objective on shares of Cross Country Healthcare from $24.00 to $21.00 and set a buy rating on the stock in a report on Thursday, February 22nd. Truist Financial decreased their price objective on shares of Cross Country Healthcare from $22.00 to $16.00 and set a hold rating on the stock in a report on Thursday, February 22nd. TheStreet lowered shares of Cross Country Healthcare from a b- rating to a c+ rating in a report on Friday, March 1st. Finally, Barrington Research decreased their price objective on shares of Cross Country Healthcare from $26.00 to $24.00 and set an outperform rating on the stock in a report on Tuesday, February 27th. Six investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Cross Country Healthcare presently has a consensus rating of Hold and an average price target of $21.67.

Insider Buying and Selling at Cross Country Healthcare

In other Cross Country Healthcare news, insider Karen Mote sold 6,216 shares of the stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $16.95, for a total value of $105,361.20. Following the sale, the insider now directly owns 35,101 shares of the company’s stock, valued at approximately $594,961.95. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 4.90% of the company’s stock.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.